Blossom publishes several articles per week that provide commentary on the developing field of psychedelics as medicine. Here we analyse the latest research, provide overviews of research areas, and conduct interviews with leading psychedelic figures.
It's been quite a few months since the last update (May). In that time, Blossom has continued to expand, with us now having full summaries of nearly 2000 research articles. When we hit this milestone (probably mid November), I will make a bit of a splash around it.
Even as many of us took time off for summer vacations, researchers in the field of psychedelics persisted in their efforts. They delved deeper into understanding the healing properties of these substances. The big psilocybin for depression (MDD) by the non-profit Usona was published, we got new insights into candy flipping (MDMA + psychedelic) from two groups, and the risks of prolonged microdosing.
Blossom provides timely and timeless information on psychedelics as medicine. Our blogs, articles, and interviews help contextualize this quickly developing field of psychedelic research and how this will be implemented.